Physician profile
Clinton Michael Cloud
NPI 1538793880
$1,243.30
in general payments reported to CMS, 2019-2025
23 companies · $373 in 2025
The $373 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $133 · 2023: $524 · 2024: $213 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $992 · Education: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $991.65 |
| Education | $119.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $197.42 | 2022-2025 | Fasenra, Tezspire, Breztri |
| United Therapeutics Corporation | $127.04 | 2022-2024 | Tyvaso |
| Jazz Pharmaceuticals INC. | $120.16 | 2023 | |
| Glaxosmithkline, LLC. | $103.04 | 2022-2025 | Nucala |
| Abbvie INC. | $102.42 | 2022-2024 | |
| Insmed, INC. | $73.11 | 2025 | Arikayce |
| Mylan Specialty L.P. | $71.92 | 2023 | Yupelri |
| Csl Behring | $63.25 | 2023-2024 | Kcentra |
| Regeneron Healthcare Solutions, INC. | $56.01 | 2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $47.44 | 2023-2024 | |
| Genzyme Corporation | $39.16 | 2025 | |
| Amgen INC. | $32.69 | 2023-2024 | Tezspire |
| Baxter Healthcare | $26.55 | 2023 | Hillrom - Life 2000 Ventilation System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.27 | 2025 | Jascayd |
| Ani Pharmaceuticals, INC. | $20.28 | 2023 | Purified Cortrophin Gel |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $20.14 | 2025 | Prolastin-C Liquid |
| Zoll Respicardia, INC. | $20.04 | 2023 | Remede System |
| Actelion Pharmaceuticals US, INC. | $18.52 | 2024 | Opsumit, Uptravi |
| Genentech USA, INC. | $17.53 | 2025 | Xolair |
| Viatris Specialty LLC | $17.30 | 2025 | Yupelri |
| Mallinckrodt Hospital Products INC. | $16.29 | 2023 | Acthar |
| Idorsia Pharmaceuticals US INC | $16.23 | 2022 | |
| Lilly USA, LLC | $13.49 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clinton Cloud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.